top of page


FDA approves Kerendia for chronic kidney disease associated with type 1 diabetes
The FDA has expanded the approved use of Kerendia to adults with chronic kidney disease associated with type 1 diabetes, introducing a new treatment option for this high-risk population.

nuaxia
Sep 182 min read


Renalytix and Quest Diagnostics partner to expand kidneyintelX.dkd testing across the US
Renalytix has signed a multi-year agreement with Quest Diagnostics to expand US access to its kidneyintelX.dkd blood test for patients with type 2 diabetes and chronic kidney disease.

nuaxia
Sep 21 min read
bottom of page